A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
Abstract
Purpose: The study objective was to characterize the prognostic performance of a novel Breast Cancer Index model (BCIN+), an integration of BCI gene expression, tumor size, and grade, specifically developed for assessment of distant recurrence (DR) risk in HR+ breast cancer patients with one to three positive lymph nodes (pN1).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 30, 2017
- Source ID
- 10.1158/1078-0432.ccr-17-1688
Entities
People
- Amy Ly
- Brock E. Schroeder
- Catherine A. Schnabel
- Dennis C. Sgroi
- Hannah Nolan
- Piiha-lotta Jerevall
- Yi Zhang
Organizations
- United States Department of Defense